References
Aaltonen LA, Peltomaki P, Leach FS, Pyllanen L, Sistonen P, Mecklin JP, Jarvinen H, Powell SM & Hamilton SR (1993). Clues to the pathogenesis of familial colorectal cancer. Science 260: 812–816.
Armitage P (1952). The statistical theory of bacterial populations subject to mutation. J Roy Stat Soc Ser B 14: 1–40.
Aukerman SL, Siciliano MJ & Fidler IJ (1986). Heterogeneity of isozyme expression in tumor cells does not correlate with metastatic potential. Clin Exp Metastasis 4: 177–189.
Baylin SB, Weisburger WR, Eggleston JC, Mendelsohn G, Beaven MA, Abeloff MD & Ettinger DS (1978). Variable content of histaminase, L-dopa decarboylase and calcitonin in small-cell carcinoma of the lung. Biologic and clinical implications. New Engl J Med 299: 105–110.
Byers VS & Johnston JO (1977). Antigenic diferenes amomg osteogenic sarcoma tumor cells taken from different locations in human tumors. Cancer Res 37: 3173 et seq.
Cifone MA & Fidler IJ (1981). Increasing metastatic potential is associated with increasing genomic instability of clones isolated from murine neoplasms. Proc Natl Acad Sci USA 78: 6949–6952.
Emmert-Buck MR, Bonner RF, Smith PD et al. (1996). Laser capture microdissection. Science 274: 998–1001.
Fend F, Emmert-Buck MR & Chuaki R (1999). Laser capture microdissection of immuno-stained frozen sections for mRNA analysis. J Pathol 154: 61–66.
Fialkow PJ (1979). Clonal origin of human tumors. J Amer Med Assoc 30: 135–143.
Ford CE & Clarke M (1963). Cytogenetic evidence of clonal proliferation in primary reticular neoplasms. Canad Cancer Res Conf Proc 5: 129–146.
Goldberg S & Defendi V (1979). Increased mutation rates in doubly viral transformed Chinese hamster cells. Somatic Cell Genet 5: 887–895.
Hartwell L (1992). Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 71: 543–546.
Heppner GH, Miller BE & Miller FR (1983). Tumor subpopulation interactions in neoplasms. Biochim Biophys Acta 695: 215–226.
Kaden D, Gadi IK, Bardwell L, Gelman R & Sager R (1989). Spontaneous mutation rates of tumorigenic and nontumorigenic chinese hamster embryo fibroblast cell lines. Cancer Res 49: 3374–3379.
Kendal WS & Frost P (1986). Metastatic potential and spontaneous mutation rates: studies with two murine cell lines and their recently induced metastatic variants. Cancer Res 46: 6131–6135.
Kerbel RS, Waghorne C, Man Ms, Elliott B & Brietman ML (1987). Alteration of the tumorigenic and metastatic properties of neoplastic cells is associated with the process of calcium phosphate mediated DNA transfection. Proc Natl Acad Sci USA 84: 1263–1267.
Kern SE (1993). Clonality: more than just a tumor-progression model. J Natl Cancer Inst 85: 1020–1021.
Kyner D, Christman J, Acs G, Silagi S, Newcomb EW & Silverstein SC (1978). Co-cultivation of tumorigenic mouse melanoma cells with cells of a non-tumorigenic subclone inhibits plasminogen activator expression by the melanoma cells. J Cell Physiol 95: 159–167.
Leith JT, Michelson S, Faulkner LE & Bliven SF (1987). Growth properties of heterogenous human colon tumors. Cancer Res 47: 1045–1051.
Lejeune J, Berger R, Haines M, Lafourcade J, Vialatte J, Satge P & Turpin R (1963). Constitution d'un clone ´a 54 chromosomes au cours d'une leucoblastose chez une enfant mongolienne. CR Acad Sci (Paris) 256: 1195–1197.
Lenoir GM, Preud'homme JL, Bernheim A & Berger R (1982). Correlation between immunoglobulin light chain expression and variant translocation in Burkitt's lymphoma. Nature 298: 474–476.
Luria SE & Delbr¨uck M (1943). Mutations of bacteria from virus sensitivity to virus resistance. Genetics 28: 491–511.
Michelson S, Miller BE, Glicksman AE & Leith JT (1987). Tumor microecology and competitive interactions. J Theoret Biol 128: 233–246.
Miller BE, Miller FR, Wilburn D & Heppner G (1988). Dominance of a tumor subpopulation line in mixed heterogenous mouse mammary tumors. Cancer Res 48: 5747–5753.
Mitelman F (1991). “Catalogue of Chromosomal Aberrations in Cancer.” 4th Edition. Wiley-Liss: New York.
Muleris M, Salmon RJ & Dutrillaux B (1986). Chromosomal study demonstrating the clonal evolution and metastatic origin of a metachronous colorectal carcinoma. Int J Cancer 38: 167–172.
Newcomb EW, Silverstein SC & Silagi S (1978). Malignant mouse melanoma cells do not form tumors when mixed with cells of a non-malignant sub-clone: relationships between plasminogen activator expression by the tumor cells and the host's immune response. J Cell Physiol 95: 169–177.
Nowell PC (1976). The clonal evolution of tumor cell populations. Science 194: 23–28.
Peinado MA, Malkhosyan S, Velasquez A & Perucho M (1992). Isolation and characterization of allelic losses and gains in colorectal tumors by arbitrarily primed polymerase chain reaction. Proc Natl Acad Sci USA 89: 10065–10069.
Perdue ML (1991). Dynamic instability of chromosomes and genomes. Cell 66: 427–431.
Russo CA, Weber TK, Volpe CM, Stoler DL, Petrelli NJ, Rodriguez-Bigas M, Burhans WC & Anderson GR (1995). An anoxia-inducible endonuclease and enhanced DNA breakage as contributors to genomic instability in cancer. Cancer Res 55: 1122–1128.
Sager R (1988). Mutation rates and mutational spectra in tumorigenic cell line. Cancer Surv 7: 325–333.
Sandberg AA & Yamada K (1966). Chromosomes and causation of human cancer and leukemia. I Karyotypic diversity in a single cancer. Cancer 19: 1869–1878.
Sandberg AA, Yamada K, Kikuchi Y & Takagi N (1967). Chromosomes and causation of human cancer and leukemia. III Karyotypes of cancerous effusions. Cancer 20: 1099–1116.
Seshadri R, Kutlaka RJ, Trainor K, Matthews C & Morley AA (1987). Mutation rate of normal and malignant human lymphocytes. Cancer Res 47: 407–409.
Sirivatanauksorn Y, Drury R, Crnogorac-Jurcevic T, Sirivatanauksorn V & Lemoine N (1999). Laser-assisted microdissection: Applications in molecular pathology. J Pathol 189: 150–154.
Tisty TD (1995). Cell cycle control and genomic instability. Cancer Metastasis Rev 14: 1–2.
Tisty TD, Margolin BH & Lum K (1989). Differences in the rates of gene amplification in nontumorigenic and tumorigenic cell lines as measured by Luria-Debr¨uck fluctuation analysis. Proc Natl Acad Sci USA 86: 9441–9445.
Trent JM (1984). Chromosomal alterations in human solid tumours: implications of the stem cell model to cancer cytogenetics.
Trent JM, Thompson FH & Ludwig C (1984). Evidence for selection of homogeneously staining regions in a human melanoma cell line. Cancer Res 44: 233–237.
Trent JM, Thomson FH & Buick RN (1985). Generation of clonal variants in a human ovarian carcinoma studied by chromosomal banding analysis. Cancer Genet Cytogenet 14: 153–161.
Virchow R (1858). “Die Cellular pathologie in ihrer Bergundung auf Physiologie und pathologischeGewebelehre.” Hirschwald: Berlin.
Vogel F & Motulsky AG (1979). “Human Genetics. Problems and Approaches.” p. 317 Springer-Verlag: New York.
Vogelstein B, Fearon ER, Hamilton SR & Feinberg AP (1988). Genetic alterations during colorectal tumor development. N Engl J Med 319: 525–532.
Windle B, Draper BW, Yin YX, O'Gorman S & Wahl GM (1991). A central role for chromosome breakage in gene amplification, deletion formation, and amplicon integration. Genes Dev 5: 160–174.
Wolff J (1907). “The Science of Cancerous Disease from Earliest Times to the Present” Trans B Ayoub (1989) Science History Publications: Canton MA
Wolman SR (1983) Karyotypic progression in human tumors. Cancer Metastasis Revs 2: 257–293.
Wolman SR (1986). Cytogenetic Heterogeneity: Its role in tumor evolution. Cancer Genet Cytogenet 19: 129–140.
Yamashina K & Heppner GH (1985). Correlation of frequency of induced mutation and metastatic potential in tumor cell lines from a single mouse mammary tumor. Cancer Res 45: 4015–4019.
Rights and permissions
About this article
Cite this article
Weiss, L. Cancer Cell Heterogeneity. Cancer Metastasis Rev 19, 345–350 (2000). https://doi.org/10.1023/A:1010614909387
Issue Date:
DOI: https://doi.org/10.1023/A:1010614909387